Midline Catheter Versus Long Peripheral Intravenous Catheter in Hospitalized Adult Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-02

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research seeks to compare two types of vascular access (catheters that are inserted into the vein) for patient treatment during hospitalization. This research will evaluate how long each catheter lasts before presenting problems that may lead to its removal from the vein (the most common are swelling on the site of the catheter, clogging of the catheter, infections, or other less common problems. Each patient will be randomly selected to receive either catheter. In this study, we will also estimate how much each patient will spend if any of the problems mentioned occur.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison Between Mini-midline and the Peripheral Intravenous Catheter

NCT06290284

Vascular Access Devices Venous Puncture

COMPLETED NA

CVCs Versus Midline Catheters

NCT06884176

Central Venous Catheter Midline Catheter Complication of Catheter

NOT_YET_RECRUITING NA

Midline Catheters Versus Peripheral Catheters in Internal Medicine Unit

NCT05512117

Vascular Access Complication Vascular Access Device Complications

COMPLETED NA

Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

NCT06014099

Catheter Complications

NOT_YET_RECRUITING NA

Prospective Evaluation of Complications of MidLine Catheters in the ICU

NCT05412108

Catheter Complications

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized, parallel, open, controlled, single-center clinical trial is blind to outcome analysis. The use of midline catheter will be compared, regarding duration of use without complications, to the use of long peripheral intravenous catheter during continuous our intermittent intravenous therapy in adult clinical patients who have been hospitalized for up to 30 days. The intervention group will consist of hospitalized adult clinical patients who were identified with difficult intravenous access (DIVA) and who received medical indication of continuous or intermittent intravenous therapy for more than five and a maximum of 30 days of treatment. These patients will receive PowerGlide ProTM Midline catheter. The control group will consist of patients with the same profile described as the intervention group and will receive the insertion of a long peripheral venous catheter Introcan Safety Deep Access. At the end of the study, an economic analysis will be carried out from the perspective of the public health system if the intervention group shows favorable results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Access Devices

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized, parallel, open, controlled, and single-center clinical trial.

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

This study will be blind to statistical analysis.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PowerGlide Pro Midline catheter.

The Intervention Group will be represented by hospitalized adult clinical patients who have been identified with difficult intravenous access. These patients will receive an ultrasound-guided insertion of the PowerGlide ProTM Midline 20G (10 cm).

Group Type EXPERIMENTAL

PowerGlide Pro Midline catheter.

Intervention Type DEVICE

The Intervention Group will be represented by hospitalized adult clinical patients who have been identified with difficult intravenous access. These patients will receive an ultrasound-guided insertion of the PowerGlide ProTM Midline 20G (10 cm).

Introcan Safety Deep Access long peripheral venous catheter.

The control group will be subjected to the same selection criteria as the patients in the intervention group; however, they will receive an ultrasound-guided insertion of a long peripheral venous catheter Introcan Safety Deep Access 20G (6.4 cm).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PowerGlide Pro Midline catheter.

The Intervention Group will be represented by hospitalized adult clinical patients who have been identified with difficult intravenous access. These patients will receive an ultrasound-guided insertion of the PowerGlide ProTM Midline 20G (10 cm).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients hospitalized in a clinical ward unit;
* indicated for continuous or intermittent intravenous therapy more than five days;
* identified with difficult intravenous access.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No